As of Sep 23
| -0.05 / -1.74%|
The 6 analysts offering 12-month price forecasts for ImmunoGen Inc have a median target of 5.50, with a high estimate of 20.00 and a low estimate of 2.50. The median estimate represents a +95.04% increase from the last price of 2.82.
The current consensus among 8 polled investment analysts is to Hold stock in ImmunoGen Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.